Home > Cluster Organisations > BioM Biotech Cluster Development GmbH

BioM Biotech Cluster Development GmbH

Primary tabs

Printer-friendly versionPrinter-friendly version
General Information
The date when the cluster organisation was established: 
Wednesday, 18 June, 1997
Number of staff in the management team of the cluster organisation : 
1-5
Regions: 
Oberbayern
Other Label: 
European Gold Label for Cluster Excellence (2013); national Leading-Edge Cluster for Personalized Medicine (BMBF)
Membership to European Strategic Cluster Partnerships (ESCP-4i or ESCP-S3): 
Membership to other networks/partnerships: 
NameWebsite
Start.Smart.Global
CEBR Council of European BioRegions
Cluster Management Team: 
NameSurnamePositionTelephoneGender
Prof. Horst
Domdey
Cluster Manager
0049898996790
Male
Languages spoken: 
English
German
Sectoral and Industrial Focus
Sectoral Industries: 
Biopharmaceuticals
Technology fields: 
Genetic Engineering
Gene Expression, Proteome Research
S3 EU priority areas: 
e-Health (e.g. healthy ageing)
Human health activities (medical services)
Emerging industries: 
Biopharmaceuticals
Composition of the cluster
Total number of members: 
360
Number of SME members: 
180
Number of start-ups among SME members: 
60
Number of larger company members: 
50
Number of other ecosystem actors : 
130
Entrepreneurship and scale-up support facilities in the cluster's ecosystem (see "Organisation type"): 
Organisation/Facility NameOrganisation/Facility TypeWebsite
BioM
Accelerator
Name and link of major players: 
Cluster Strategy
Mission/Objectives: 

Bavaria: the Place for the Medicine of the Future

BioM recognizes the challenges of the medicine of the future and supports its development by identifying and connecting matching partners from science, industry, medicine and finance. BioM supports the innovation process by developing and providing targeted measures and customized instruments.

Since 1997, BioM is the network organization of the biotechnology sector in Munich and in Bavaria, commissioned by the Bavarian Ministry of Economic Affairs. Approximately 270 biotechnological and pharmaceutical companies are present in the metropolitan area of Munich. The core competence of the region is the development of innovative therapeutics and diagnostics, in particular for personalized healthcare. BioM supports the Bavarian biotechnological and pharmaceutical sector with an extensive network for developing new business contacts. The cluster management offers central access and a broad range of information about the sector for prospective customers from home and abroad.

BioM manages a broad range of training sessions, events and network meetings "by experts for experts" as well as for start-ups. BioM provides comprehensive consulting and specialized coaching, training and mentoring programs especially for those start-ups. In total, BioM has supported more than 200 start-up companies in 20 years.

Do you have a formalised strategy?: 
No
Do you have a specific strategy focus that addresses internationalisation ?: 
No
Services
Support services provided: 
Access to public support (regional/national programmes, innovation vouchers, etc.)
Access to private funding (connecting to investors, seed-capital, venture-capital, crowd-funding, etc.)
Facilitation of collaboration between members
Provision and facilitation of access to training for members
Location promotion / attraction of Foreign Direct Investment
Details of support services: 

Scouting Partnering BioM identifies innovations in Bavarian companies and research institutes and establishes contacts between potential partners.

Grant & Financing Advisory We support you in selecting the appropriate funding for research and development. We advise on financing opportunities.

Start-up Support Services BioM GmbH offers extensive and individual support to start-ups and young entrepreneurs in medical biotechnology. We support you in developing a viable business model and in setting up a plausible business plan. We help you identify the right financing and funding opportunities. In addition to our many years of experience, we provide you with a comprehensive network of industry representatives, investors and other relevant stakeholders. Together with our partners, we support you from your research idea till your successful start-up. You can find an overview of our service in our brochure BioM for BioEntrepreneurs (pdf).

International Affairs BioM supports Bavarian companies in international activities and is the main access port for incoming business partners to the Bavarian biotechnology industry.

Marketing Services for the biotech hot spot Munich/Bavaria concerning public relations and marketing.

Job Market The portal for life sciences specialists and managers in Bavaria - relevant, regional and well-known.

Cooperation Activities
International Cooperation
The main countries targeted by the cluster organisation: 
Canada
China
Japan
Republic of Korea (South Korea)
United States
Our cluster organisation undertook the following international activities to support our members: 
Participation at missions/events/study visits/fairs
Trans-national Cooperation
The main countries targeted by the cluster organisation: 
France
Italy
Spain
United Kingdom
Our cluster organisation undertook the following trans-national activities to support our members: 
Participation at missions/events/study visits/fairs
Please explain: 

BioM is an active member of CEBR (Council of European BioRegions; www.cebr.net).

BioM has been / is partner in several European cluster consortia, e.g. bioXclusters (www.bioXclusters.eu)

BioM maintains event partnerships with European regions and actively participates in BIO-Europe and BIO-Europe Spring.

Which clusters do you collaborate with?: 
Lyonbiopole (France)
bioPmed (Italy)
Biocat (Spain)
Medicen (France)
Support Programmes
Participation in Funded Support Programmes: 
European ProgrammesProject NameLinkName & Description (Regional/National)Link (Regional/National)
H2020
CIP/COSME
INTERREG
EIT KICs
Promotion
Success Story / Achievements: 

BioM Biotech Cluster Development GmbH - Achievements

Why should partners choose you for cooperation?: 

Bavarian Biotech News - Highlights